副产品对主体比率用于评估矿产资源的可访问性
Titouan Greffe1, Max Frenzel2, Tim T Werner3
1CIRAIG, Institute of Environmental Sciences, UQAM, Montreal, Quebec H2X 3Y7, Canada.
Environmental science & technology
|December 4, 2024
概括
关键次要元素的未来供应,如和,取决于主要商品. 本研究引入了副产品与主机的比率,以预测它们对净零技术的可用性.
科学领域:
- 地质科学 地质科学
- 资源经济学 资源经济学
- 材料科学 材料科学 材料科学
背景情况:
- 净零野心需要能源和流动性的多样化矿产资源.
- 小元素 (例如,,) 是至关重要的,但它们的供应是不太了解.
- 这些元素往往是主要商品采矿的副产品,造成供应依赖.
研究的目的:
- 开发一种方法来评估未来的次要元素供应.
- 量化矿产矿床中副产品和主体商品之间的关系.
- 解决矿产供应情景中关于副产品依赖性的差距.
主要方法:
- 统一的分散矿产资源估计数据.
- 使用矿石量和元素等级计算了副产品与主体 (BtH) 的比率.
- 从全球3422个存款中编制了22,275个BtH比率的数据集.
主要成果:
- 开发了一种新的BtH比率方法.
- 创建了BtH比率的全面全球数据集.
- 建立了一种方法来从宿主元素生产中获得未来的次要元素供应.
结论:
- 未来的次要元素供应与主要商品生产密切相关.
- BtH比率为更准确的矿物供应预测提供了一个框架.
- 这一开放式数据集将有助于未来的研究和关键材料的资源管理.
相关概念视频
Production Efficiency
15.7K
Net production efficiency (NPE) is the efficiency at which organisms assimilate energy into biomass for the next trophic level. Due to low metabolic rates and less energy spent on thermoregulatory processes, the NPE of ectotherms (cold-blooded animals) is 10 times higher than endotherms (warm-blooded animals).
15.7K
Porosity and Absorption of Aggregate
1.0K
Aggregates contain pores of varying sizes; while some are completely enclosed within the particles, others open onto the surface, allowing water to penetrate. The porosity of aggregates is a major factor contributing to the overall porosity of concrete, given that aggregates constitute about three-quarters of concrete's volume.
When all pores in an aggregate are filled with water, the aggregate is considered saturated and surface-dry. If left in dry air, water will evaporate until the...
When all pores in an aggregate are filled with water, the aggregate is considered saturated and surface-dry. If left in dry air, water will evaporate until the...
1.0K
Bioavailability Study Design: Absolute Versus Relative Bioavailability
648
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
648
Measurement of Bioavailability: Pharmacokinetic Methods
517
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
517
Measurement of Bioavailability: Pharmacodynamic Methods
1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K
Drug Product Performance: In Vitro–In Vivo Correlation
431
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
431


